EP2970456

SHIRE HUMAN GENETIC THERAPIES, INC.
Application Number
EP14717945A
Filing Date
Mar 14, 2014
Status
Granted And Under Opposition
Apr 16, 2021
Grant Date
May 19, 2021
External Links
Slate, Register

Biblio Summary

The patent EP2970456B1 was granted on May 19, 2021 by Shire Human Genetic Therapies, Inc. The patent is currently Granted And Under Opposition.

The table below shows 4 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

EIP LIMITEDFeb 21, 2022ADMISSIBLE
STRAWMAN LIMITEDFeb 18, 2022ADMISSIBLE
WITHERS & ROGERS LLPFeb 18, 2022ADMISSIBLE
GLAXOSMITHKLINE BIOLOGICALS SAFeb 18, 2022WITHDRAWN

The table below shows the patents of Shire Human Genetic Therapies, Inc. that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP2858679Pulmonary Delivery Of Mrna To Non-Lung Target CellsJun 5, 20241
EP3626258Methods And Compositions For Cns Delivery Of Iduronate-2-SulfataseAug 4, 20211
EP3103469Cns Delivery Of Therapeutic AgentsDec 9, 20201